Cardiodx
Redwood City, US · Delaware corporation · 1 known investors
Founders & leadership
MM
Mark MonaneExecutive
GR
Gwen R. CarscaddenExecutive
DL
David L. LevisonExecutive
DL
Deborah L. KilpatrickExecutive
RF
Robert F. WernerExecutive
DT
Douglas T. RossExecutive
MG
Melinda GriffithExecutive
Board
PG
Patrick G. EnrightBoard director
LL
Louis LangeBoard director
AS
Ajit SinghBoard director
HH
Hongjie HuBoard director
BH
Brook H. ByersBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$51.5M disclosed across 3 rounds · 2014–2017
▶$18.1MraisedJan 2017 · 7 investors · BiotechnologyRule 506(b)
▶$18.1MraisedJan 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hongjie HuDirector
- Mark MonaneExecutive Officer
- Patrick G. EnrightDirector
- Ajit SinghDirector
- David L. LevisonDirector
- Tim HennExecutive Officer
- Khushro F. MehtaExecutive Officer, Director
- Susan DanielsExecutive Officer
- Jim WingroveExecutive Officer
- Duane WilliamsExecutive Officer
- Offering amount
- $41.8M
- Amount sold
- $18.1M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.4MraisedFeb 2016 · 15 investors · BiotechnologyRule 506(b)
▶$12.4MraisedFeb 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark MonaneExecutive Officer
- Patrick G. EnrightDirector
- Gwen R. CarscaddenExecutive Officer
- Louis LangeDirector
- Andrew L. GuggenhimeDirector
- James R. TobinDirector
- David L. LevisonExecutive Officer, Director
- Ajit SinghDirector
- Hongjie HuDirector
- Offering amount
- $25.5M
- Amount sold
- $12.4M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21MraisedJul 2014 · 14 investors · BiotechnologyRule 506(c)
▶$21MraisedJul 2014 · 14 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Patrick G. EnrightDirector
- David L. LevisonExecutive Officer, Director
- Mark MonaneExecutive Officer
- Brook H. ByersDirector
- Deborah L. KilpatrickExecutive Officer
- Robert F. WernerExecutive Officer
- Andrew L. GuggenhimeDirector
- Douglas T. RossExecutive Officer
- Melinda GriffithExecutive Officer
- Ajit SinghDirector
- Gwen R. CarscaddenExecutive Officer
- Louis LangeDirector
- James R. TobinDirector
- Offering amount
- $25M
- Amount sold
- $21M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cardiodx's investors?
- Cardiodx's investors include Pappas Capital.
- How much funding has Cardiodx raised?
- Cardiodx has disclosed $51.5M raised across 3 rounds.
- Where is Cardiodx headquartered?
- Cardiodx is headquartered in Redwood City, US.